AsiaNet  87830

BOLOGNA, Italy, Jan. 28, 2021 /PRNewswire=KYODO JBN/ --

Online doctorAsyou, a web platform entirely dedicated to physicians

The website optimizes research on the most important and autoritative medical

databases such as Pubmed, ICTRP and ClinicalTrials.gov.

An entirely new area presents online courses for physicians on several

different topics

Alfasigma has recently launched a number of digital activities that expand its

web presence and improves its touchpoints around the world.

doctorAsyou – online at www.doctorasyou.com - is a web portal entirely

dedicated to physicians with two main areas: online scientific research and

medical training development.

The Website database optimizes and simplifies online research process of

scientific medical information, for a continuous updating, necessary to face

clinical decisions in the best possible way.

The database is updated daily and returns a total of about 30 million

abstracts, combining the three most authoritative databases in the world such

as PubmedICTRP  and ClinicalTrials.gov.

This comprehensive database is able to discover articles and original

researches, keeping users up to date with health and medical developments in

order to stay ahead and improve patient care. It's available also a virtual

library, useful to    manage in different folders all saved publication and

search interests. doctorAsyou is focused on first-hand clinical information, in

fact it filteres out non relevant documents types from PubMed (e.g. video,

editorials, books) and improves with other sources.

Pier Vincenzo Colli, CEO of Alfasigma declares: "doctorAsyou is a relevant

investment that Alfasigma has done in favor of the global scientific community

in order to facilitate research work and continuous medical development of

healthcare professionals. It's another important step in our digital

transformation entirely dedicated to serve psysicians and reserarrchers around

the world. The scope goes beyond our focus in gastro-intestinal, vascular and

rheumatological therapeutic areas, because also this project is consistent with

our corporate social responsibility effort to support research and development

in all scientific areas."  

The second area is made up with high-level training programs that permit to

advance professional careers and build users' confidence with a 3-6 month

action-oriented learning experience made up of cohort and self-paced courses,

designed and taught by a global experts community. Educational activities are

delivered in a wide variety of formats that are intended to facilitate paying

attention and remembering what is learned. At the same time the courses can be

attended anytime and anywhere. A number of topics are covered such as Writing

in Science, Medication Adherence Definition, Tools, & Statistics, Internet of

Medical Things in Healthcare, Communication Skills For Surgeons, A Data-Driven

Approach to Improve Patient Care and others.

More info.

Pubmed comprises over 30 million citations for biomedical literature from

MEDLINE, life science journals, and online books. PubMed citations and

abstracts include the fields of biomedicine and health, covering branches of

the life sciences, behavioral sciences, chemical sciences, and bioengineering.

ICTRP: International Clinical Trial Registry Platform is a service set up by

the World Health Organisation (WHO) to ensure that information regarding

clinical trials is accessible to all those involved in healthcare decision

making.

Clinicaltrials.gov: it's a database of privately and publicly funded clinical

studies conducted in 50 states and in 216 countries. ClinicalTrials.gov is a

resource provided by the U.S.  national Library of Medicine and it includes

around 350,000 research studies.

About Alfasigma

Privately owned, Alfasigma is one of the leading Italian pharmaceutical

companies, present in over 90 countries, through distributors and subsidiaries

and has a workforce of around 3,000 people, R&D laboratories, and 5 production

plants.

In Italy, Alfasigma is a leader in the market for prescription products where,

in addition to the strong focus on gastrointestinal, it is present in many

primary care therapeutic areas. Alfasigma also produces and markets

self-medication products, nutraceuticals and food supplements.

More information is available at the corporate website

https://www.alfasigma.com    

Logo - https://mma.prnewswire.com/media/1325576/Alfasigma_Logo.jpg

Source: Alfasigma